PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.20 | 0.24% | 84.54 | 84.68 | 84.285 | 84.44 | 84.34 | 09:50:16 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,752 | 234,601 | $ 84.39 | $ 19,799,139 | 8,174,661 | 66.10 - 87.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:50:16 | 100 | $ 84.54 | USD |
Merck Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 216.45B | 2.56B | $ 6.22B | 2.32 | 22.90 | 2.56B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 17.98M | $ 1.99 | 2.35% | 09/13/19 | 19.00 | 0.10% |
Merck News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/08/2019 | 19:00 | GlobeNewswire Inc. | BriaCell Therapeutics Corp. to File Amendment to Management.. |
| 10/08/2019 | 09:55 | Dow Jones News | Merck Cuts Emissions by 7% |
| 10/08/2019 | 08:00 | Business Wire | Merck Issues 2018/2019 Corporate Responsibility Report |
| 10/08/2019 | 04:55 | Dow Jones News | 4D Pharma Enters Vaccine Collaboration With Merck & Co. |
| 10/07/2019 | 06:30 | GlobeNewswire Inc. | BriaCell Doses First Patient in Phase I/IIa Study Evaluating.. |
| 10/03/2019 | 10:39 | Dow Jones News | PDS Biotechnology Shares Up 38% on Merck Collaboration |
| 10/03/2019 | 09:28 | Dow Jones News | NetScientific Shares Jump as Portfolio Company PDS.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 85.03 | 85.44 | 83.08 | 83.9455 | 6M | -0.49 | -0.58% |
| 1 Month | 82.01 | 85.87 | 80.54 | 83.7450 | 8M | 2.53 | 3.08% |
| 3 Months | 81.68 | 87.5 | 78.85 | 84.0241 | 8M | 2.86 | 3.50% |
| 6 Months | 79.47 | 87.5 | 72.23 | 81.7433 | 10M | 5.07 | 6.38% |
| 1 Year | 69.19 | 87.5 | 66.1 | 78.9157 | 11M | 15.35 | 22.19% |
| 3 Years | 62.72 | 87.5 | 52.83 | 67.6239 | 10M | 21.82 | 34.79% |
| 5 Years | 56.57 | 87.5 | 45.69 | 63.2222 | 10M | 27.97 | 49.44% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the company's sales are generated in the United States. |
